Camilla Foged

Ph.D. (Farmaci), MS (Biokemi), BS (Biokemi)

20022019

Publikationer pr. år

Netværk

Else Marie Agger

  • Statens Serum Institut

Ekstern person

Karen Smith Korsholm

  • Statens Serum Institut

Ekstern person

Dennis Christensen

  • Statens Serum Institut

Ekstern person

Dennis Christensen

  • Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut

Ekstern person

Peter Andersen

  • Statens Serum Institut

Ekstern person

Simon Bjerregaard

  • Novo Nordisk A/S (Biz)

Ekstern person

Morten Jonas Maltesen

  • Novozymes Biopharma A/S

Ekstern person

Else Marie Agger

  • Statens Serum Institut

Ekstern person

Martin Malmsten

  • Uppsala University

Ekstern person

Jens Hansen

  • LEO-Pharma

Ekstern person

Giovanni M. Pavan

  • University of Applied Sciences of Southern Switzerland

Ekstern person

Ida Rosenkrands

  • Statens Serum Institut

Ekstern person

Gert Storm

  • Utrecht University

Ekstern person

Tommy Nylander

  • Dept. Chemistry, Univ. Lund

Ekstern person

S. Gehrig

  • University of Zurich

Ekstern person

Monique Gangloff

  • University of Cambridge

Ekstern person

Yvonne Perrie

  • Aston University

Ekstern person

Twan Lammers

  • Utrecht University

Ekstern person

Roland Lang

  • Universitätsklinikum Erlangen

Ekstern person

Claus-Michael Lehr

  • Helmholtz Institute for Pharmaceutical Research Saarland

Ekstern person

Saeid Koocheki

  • Razi University

Ekstern person

Mattias Hallbrink

  • Stockholm University

Ekstern person

E. Agger

  • FARMA

Ekstern person

Thorsten Thormann

  • LEO-Pharma

Ekstern person

Matthew Bunker

  • Molecular Profiles Ltd

Ekstern person

Zeynab Nosrati

  • University of British Columbia

Ekstern person

Andrea Danani

  • University of Applied Sciences of Southern Switzerland

Ekstern person

Pall Thor Ingvarsson

  • Statens Serum Institut

Ekstern person

Adam Bohr

  • University College London

Ekstern person

Silke Roovers

  • Ghent University

Ekstern person

Sarah Hook

  • University of Otago

Ekstern person

Shervin Bahrami

  • Aarhus Universitet

Ekstern person

Peter Andersen

  • Statens Serum Institut

Ekstern person

Anne Sundblad

  • Karolinska University Hospital

Ekstern person

Bernard C M Te Boekhorst

  • Eindhoven Universtiy of Technology

Ekstern person

Madlen Hubert

  • School of Pharmacy and ‡Department of Chemistry, University of Otago , P.O. Box 56, Dunedin 9054, New Zealand.

Ekstern person

Raymond M. Schiffelers

  • Utrecht University

Ekstern person

Daniel Kirby

  • Aston University

Ekstern person

Brian S. Sproat

  • Chemconsilium GCV

Ekstern person

M. Malmsten

  • Uppsala University

Ekstern person

Frank Follmann

  • Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Ekstern person

Hendrik Dietz

  • Technische Universität München

Ekstern person

Paul Whitside

  • Molecular Profiles Ltd

Ekstern person

Helene Pedersen

  • Internationalt Center

Ekstern person

Jon Hansen

  • Statens Serum Institut

Ekstern person

David Scurr

  • University of Nottingham

Ekstern person

Pieter Vader

  • Utrecht University

Ekstern person

Letícia Rodrigues

  • Ludwig Maximillian Universität München

Ekstern person

Sandra Rutherford

  • Molecular Profiles Ltd

Ekstern person

J. Hansen

  • LEO-Pharma

Ekstern person

Peter Andersen

  • Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut

Ekstern person

Karen Smith Korsholm

  • Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut

Ekstern person

Jeanette Erbo Wern

  • Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Ekstern person

Katrine Bjorklund

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.

Ekstern person

Elize Van Driessche

  • Ghent University

Ekstern person

Sune Klint Andersen

  • Department of Chemical and Biochemical Engineering

Ekstern person

Koen Raemdonck

  • Ghent University

Ekstern person

Kurt Draget

  • Norwegian University of Science and Technology

Ekstern person

Else Marie Agger

  • Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut

Ekstern person

Simon Bjerregaard

  • Novo Nordisk A/S (Biz)

Ekstern person

Kasper Karlsen

  • Statens Serum Institut

Ekstern person

Fahmeed Hyder

  • Yale University

Ekstern person

Wouter Leonardus Joseph Hinrichs

  • University of Groningen

Ekstern person

Amir K Varkouhi

  • Utrecht University

Ekstern person

Frank Follmann

  • Statens Serum Institut

Ekstern person

Per Fischer

  • MinervaX ApS (Biz)

Ekstern person

Bernd Lepenies

  • Max Planck Institute of Colloids and Interfaces

Ekstern person

Gustav J Strijkers

  • Eindhoven Universtiy of Technology

Ekstern person

Carina Vingsbo Lundberg

  • Statens Serum Institut

Ekstern person

Gabriel Kristian Pedersen

  • Statens Serum Institut

Ekstern person

Helene Godiksen

  • Statens Serum Institut

Ekstern person

Tayba Sajiid Khiljii

  • Institut for farmaci og analytisk kemi, FARMA

Ekstern person

Dennis Christensen

  • Statens Serum Institut

Ekstern person

Ragnhild Djønne Salte

  • Department of Pharmacy, University of Copenhagen

Ekstern person

Broes Naeye

  • Ghent University

Ekstern person

Lan Wu

  • Shenyang Pharmaceutical University

Ekstern person

Gerhard Winter

  • Ludwig Maximillian Universität München

Ekstern person

Anders Riber Bojsen

  • Institut for Farmaci

Ekstern person

Peter Andersen

  • Statens Serum Institut

Ekstern person

Catherine Taylor Nordgård

  • Norwegian University of Science and Technology

Ekstern person

Raymond M Schiffelers

  • Utrecht University

Ekstern person

Raymond M. Schiffelers

  • University Medical Center Utrecht

Ekstern person

Kim Hejnaes

  • MinervaX ApS (Biz)

Ekstern person

Katayoun Saatchi

  • University of British Columbia

Ekstern person

Brigitte Loretz

  • Helmholtz Institute for Pharmaceutical Research Saarland

Ekstern person

Kasper Kannegård Karlsen

  • NAC, Institut for Fysik og Kemi

Ekstern person

Christine M. Papadakis

  • Technische Universität München

Ekstern person

Fabian Schneider

  • Technische Universität München

Ekstern person

Teerawan Rattanapak

  • University of Otago

Ekstern person

Raymond Schiffelers

  • Utrecht University

Ekstern person

Tullio Esposito

  • University of British Columbia

Ekstern person

Amir K. Varkouhi

  • Utrecht University

Ekstern person

Niels Bent Larsen

  • Department of Micro- and Nanotechnology, DTU Nanotech, Technical University of Denmark

Ekstern person

Klaas Nicolay

  • Eindhoven Universtiy of Technology

Ekstern person

Stefaan C. de Smedt

  • Ghent University

Ekstern person

Nishan Katuwal

  • Norwegian University of Science and Technology

Ekstern person

Cristina Rodríguez-Rodríguez

  • University of British Colombia
  • University of British Columbia

Ekstern person